The consumer division re-launched Scotch-Brite scrub pad with new packaging ... to grow strongly with significant contribution from Pharmaceutical, Automotive and General Engineering Sectors.

Eli Lilly is an R&D-focused pharma company. The continuous dividend has been paid 100+ consecutive years since 1885. The company is not a consistent dividend grower, with only 11 years of dividend ...

of which 10 stocks have a net inflow of more than 30 million yuan, and Fudan Microelectronics has a net inflow of 58.3114 million yuan, ranking first in net inflows, followed by Aojie Technology and ...

Semiconductors continued to attack, Chengdu Huawei (688709), Brite (688691), VeriSilicon ... In addition, for the pharmaceutical sector that has continued to decline in the past few years, you can pay ...

However, the stock was also likely negatively impacted by CNBC Mad Money host Jim Cramer's comments on Friday. He expressed reservations about buying shares of Recursion Pharmaceuticals in light ...

Merck and Bristol-Myers Squibb are key players in cancer treatment. Find out why MRK and BMY stocks have different prospects ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BridgeBio Pharma (BBIO – Research Report), ...

JD.com, Eli Lilly and Company, Abbott Laboratories, Veeva Systems, and Johnson & Johnson are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool.

Small biotech stocks usually aren't a great fit for risk-averse investors. However, I think aggressive growth investors might want to consider buying Madrigal Pharmaceuticals' shares. Some ...

We recently compiled a list of the 12 Best Small Cap Pharma Stocks to Buy Now. In this article, we are going to take a look at where Collegium Pharmaceutical, Inc. (NASDAQ:COLL) stands against ...

Shares of NYSE:LLY traded up $4.81 during trading on Wednesday, reaching $906.61. The stock had a trading volume of 1,939,150 shares, compared to its average volume of 3,728,997. Eli Lilly and ...

Despite these challenges, dividend stocks like DaShenLin Pharmaceutical Group offer potential stability and income, making them an attractive option for those seeking to balance risk with ...